MADISON, N.J. -- Health insurer Humana is selling a toxicology and clinical lab business, a division of its Concentra health care provider, to Quest Diagnostics Inc.
Quest, a medical lab operator, did not say Thursday how much it had paid for the business, which includes a lab in Memphis, Tenn. It's the company's third laboratory acquisition this year. Quest also said Thursday that it signed a long-term deal that makes it the main provider of workplace drug toxicology and clinical lab testing for Concentra.
Quest does not expect an impact to its 2013 adjusted earnings per share from the deal, but it does see a modest benefit next year.
The Madison, N.J., company's first-quarter net income fell 15 percent as people cut back on medical spending and more Medicare reimbursements cut into revenue.
Shares of Quest added 13 cents to $60.12 in afternoon trading, while Humana's stock fell 39 cents to $79.11.
Copyright:
(c) 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Advisor News
- The first 5 years of your career could determine the next 50
- Your client’s $3 million portfolio doesn’t tell you their insurance needs
- How life insurance can provide liquidity for wealthy families
- Retirement providers turn to digital engagement to retain assets
- Looking out for clients with diminished mental capacity
More Advisor NewsAnnuity News
- What lower interest rates mean to annuity payouts
- AM Best downgrades A-Cap insurers amid financial and regulatory troubles
- Lawsuit claims Delaware Life hid billions in insurer-linked investments
- AM Best to Deliver Presentation at 2026 ACLI Annual Conference
- Global Atlantic Announces Launch of ForeLifetime Income, a New Fixed Index Annuity
More Annuity NewsHealth/Employee Benefits News
Life Insurance News